Pharma in brief - Recent developments in biosimilars: Canada, EU, France and the U.S.Adrienne M. BlanchardSophie PeléCori Annapolen Goldberg
Evidence of Patent Thickets in Complex Biopharmaceutical Technologies at http://www.wipo.intexport/sites/www/sme/en/documents/pdf/pharma licensing.pdf. new empiricalevi- dence that patent thickets are indeed present in the pharmaceutical industry The evidenceof our investigation further demonstrates tha...
In order to enrich the employees’spare time life, enhance the feelings between employees and enhance the cohesion of the company. In July and August, the company organized a one-day trip to Zhangbei Grassland for employees.
Explore the latest news and expert commentary on Pharma & Medical, brought to you by the editors of Packaging Digest
Deprenyl administration in man: a selective monoamine oxidase B inhibitor without the “cheese effect.” Psychopharmaeology 57: 33–38, 1978. CrossRef Fowler, C.J., Callingham, B.A., Mantle, T.J., and Tipton, K.F. Monoamine oxidase A and B: A useful concept ? Biochem. Pharmacol....
Antimicrobial agents are commonly divided into two major categories on the basis of their pharmacody- namics: time-dependent and concentration-dependent antibiotics. The time-dependent antibiotics, such as b-lactams, macrolides (except for azalides), tetracyclines and clindamycin, exert bactericidal ...
(Spain). According to the information provided by supplier, these products are obtained from selected food and pharma grades of high purity natural gypsum. They are characterized by high whiteness/lightness (L*), AII being an alternative of choice as a white pigment (TiO2) extender. Color ...
were employed for the fabrication of antioxidant niosomes with potential applications in food and pharma. Among the tested formulations, the Tween 80/Span 80-based ones showed the smallest size (371–393 nm in the presence of PEG 400), while the maximum particle size was noted from Tween 60...
All News #Library VKT Pharma`s Generic Famotidine Receives Approval in U.S. 28 Jan 2022 // FDA VKT Pharma`s Generic Ranolazine Receives Approval in the U.S. 19 Jan 2022 // FDA Vkt Pharma`s Generic Famotidine Receives Approval in the U.S. ...
EyePoint Pharmaceuticals, Inc. announced financial results for the third quarter ended September 30, 2022 and highlighted recent corporate developments.